ResearchMoz

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-01-23
No. Of Pages » 98
 
 
   
 This report covers major aspects of the U.S.  implantable  medical devices market. It covers the performance of the major types of implantable devices in terms of their revenue, and the market is classified according to the number of procedures performed. The overall implantable medical devices market is classified as orthopedic implants, cardiovascular implants and other (dental,  intraocular  lens and breast) implants market. The report also provides extensive analysis of the sub-segments of the market considering 2011 as the base year for market size calculations and forecast from 2012 to 2018. 
   
 The orthopedic  implants  market is classified on the basis of types of orthopedic implants and orthopedic implantation procedures. The analysis covers the estimated...
Table of Content:

Chapter1Preface
1.1ResearchScopeAndDescription
1.2Research Methodology

Chapter2ExecutiveSummary

Chapter3U.S.ImplantableMedicalDevicesMarketAnalysis
3.1Introduction
3.1.1MarketEnvironment
3.1.2PolicyIssues
3.1.3U.S.KeyIndicatorsForImplantableMedicalDevices
3.2MarketDrivers
3.2.1 HighIncidenceOfChronicDegenerativeDiseases
3.2.2IncreaseInAgingPopulation
3.2.3RiseInPurchasingParityAndIncreaseInHealthcareExpenditure
3.3MarketRestraints
3.3.1HighPriceOfImplantableDevices
3.4MarketOpportunities
3.4.1TechnicalInnovation
3.5Porter’sFiveForcesAnalysis
3.5.1BargainingPowerOfBuyers
3.5.2BargainingPowerOfSuppliers
3.5.3ThreatOfSubstitutes
3.5.4ThreatOfNewEntrants
3.5.5CompetitiveRivalry
3.6MarketAttractivenessAnalysis
3.6.1U.S.ImplantableMedicalDevicesMarket,MarketAttractivenessAnalysis,2011

Chapter4U.S.ImplantableMedicalDevicesMarket,ProductSegmentation
4.1Overview
4.1.1CurrentScenario
4.1.1.1U.S.ImplantableMedicalDevicesMarket–TrendsandForecast,2010-2018(USDMillion)
4.1.2U.S.OrthopedicImplantsMarket
4.1.2.1Currentscenario
4.1.2.2ReconstructiveJointReplacements
4.1.2.2.1U.S.ReconstructiveJointReplacementMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.3SpinalImplants
4.1.2.3.1U.S.SpinalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.4Orthobiologics
4.1.2.5Traumafixationimplants
4.1.2.6OtherImplants
4.1.3CardiovascularImplants
4.1.3.1U.S.CardiovascularImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.3.2PacingDevices
4.1.3.3StructuralCardiacDevices
4.1.3.4CardiacStents
4.1.4DentalImplants
4.1.4.1U.S.DentalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.5IntraocularLens(Iols)
4.1.5.1U.S.IntraocularLensMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.6BreastImplants
4.1.6.1U.S.BreastImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.7OtherImplants
4.1.7.1U.S.OtherImplantableMedicalDevicesMarket,TrendsandForecast,2010–2018(USDMillion)

Chapter5U.S.ImplantableMedicalDevicesMarket,ByProcedures
5.1Overview
5.2U.S.OrthopedicImplantProcedures–TrendsAndForecast,2010–2018
5.2.1U.S.OrthopedicImplantProceduresMarket,2010–2018
5.2.2KneeReplacements
5.2.3SpinalFusionAndFixation
5.2.3.1U.S.SpinalFusionandFixationProceduresMarket,TrendandForecast,2010-2018
5.2.4FractureRepairProcedures
5.3U.S.CardiovascularImplantProcedures–TrendsAndForecast,2010–2018
5.3.1U.S.CardiovascularImplantProceduresMarket,2010–2018
5.3.2StentingProcedures
5.3.2.1U.S.StentingProceduresMarket,TrendandForecast,2010–2018
5.3.3DefibrillatorImplantation
5.3.3.1U.S.DefibrillatorImplantationProceduresMarket,TrendAndForecast,2010–2018
5.4U.S.OtherImplantProcedures–TrendsAndForecast,2010–2018
5.4.1IntraocularLensImplantProcedures
5.4.2BreastAugmentation
5.4.2.1U.S.BreastAugmentationProceduresMarket,TrendandForecast,2010–2018

Chapter6CompetitiveLandscapeAndRecommendations
6.1MarketShareAnalysisOfKeyPlayers,2011
6.1MarketStrategyForSuccess
6.2BarriersToBeConsidered

Chapter7CompanyProfiles
7.1AbbottLaboratories
7.1.1CompanyOverview
7.1.2FinancialOverview
7.1.3SwotAnalysis
7.1.4ProductPortfolio
7.1.1StrategicDevelopments
7.1.1.1BusinessDiversification
7.1.1.2R&DInitiatives
7.1.1.3InvestingInEmergingMarkets
7.1.2RecentDevelopments
7.2AlconLaboratories
7.2.1CompanyOverview
7.2.2FinancialOverview
7.2.3SwotAnalysis
7.2.4ProductPortfolio
7.2.5RecentDevelopments
7.3BiometIncorporated
7.3.1CompanyOverview
7.3.2FinancialOverview
7.3.3SwotAnalysis
7.3.4StrategicDevelopments
7.3.4.1Mergers,AcquisitionsAndTakeovers
7.3.5RecentDevelopments
7.4BauschAndLombIncorporated
7.4.1CompanyOverview
7.4.2SwotAnalysis
7.4.3StrategicDevelopments
7.4.3.1Mergers,AcquisitionsAndTakeovers
7.4.3.2NewProductLaunches
7.4.4RecentDevelopments
7.5BostonScientificCorporation
7.5.1CompanyOverview
7.5.2FinancialOverview
7.5.3SwotAnalysis
7.5.4StrategicDevelopments
7.5.4.1Mergers,AcquisitionsAndTakeovers
7.5.4.2NewProductApprovals
7.5.5RecentDevelopments
7.6JohnsonAndJohnson
7.6.1CompanyOverview
7.6.2FinancialOverview
7.6.3SwotAnalysis
7.6.4StrategicDevelopments
7.6.4.1Mergers,AcquisitionsAndTakeovers
7.6.4.2NewProductApprovalsAndLaunch
7.6.5RecentDevelopments
7.7MedtronicIncorporated
7.7.1CompanyOverview
7.7.2FinancialOverview
7.7.3SwotAnalysis
7.7.4ProductPortfolio
7.7.5StrategicDevelopments
7.7.6RecentDevelopments
7.8St.JudeMedicalIncorporated
7.8.1CompanyOverview
7.8.2FinancialOverview
7.8.3SwotAnalysis
7.8.4StrategicDevelopments
7.8.4.1SignificantR&DInvestmentsForNewProductDevelopment
7.8.4.2MergersAndAcquisitions
7.8.5RecentDevelopments
7.9SmithAndNephewPlc
7.9.1CompanyOverview
7.9.2FinancialOverview
7.9.3SwotAnalysis
7.9.4StrategicDevelopments
7.9.4.1Mergers,AcquisitionsAndTakeovers
7.9.5RecentDevelopments
7.10StrykerCorporation
7.10.1CompanyOverview
7.10.2FinancialOverview
7.10.3SwotAnalysis
7.10.4StrategicDevelopments
7.10.4.1Mergers,AcquisitionsAndTakeovers
7.10.5RecentDevelopments
7.11SynthesIncorporated
7.11.1CompanyOverview
7.11.2FinancialOverview
7.11.3SwotAnalysis
7.11.4StrategicDevelopments
7.11.5RecentDevelopments
7.12ZimmerHoldingsIncorporated
7.12.1CompanyOverview
7.12.2FinancialOverview
7.12.3SwotAnalysis
7.12.4StrategicDevelopments
7.12.5RecentDevelopments

List of Tables


Table 1 The U.S. Implantable Medical Devices Market: Snapshot

List of Figures


fig. 1 U.S. Implantable Medical Devices Market, By Types Of Implants, 2011 (Usd Million)
Fig. 2 Porter’s Five Forces Analysis For The U.S. Implantable Medical Devices Market
Fig. 3 U.S. Implantable Medical Devices Market Attractiveness Analysis, 2011
Fig. 4 U.S. Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 5 U.S. Orthopedic Implants Market, 2010 – 2018 (Usd Million)
Fig. 6 U.S. Reconstructive Joint Replacement Market, 2010 – 2018 (Usd Million)
Fig. 7 U.S. Spinal Implants Market, 2010 – 2018 (Usd Million)
Fig. 8 U.S. Cardiovascular Implants Market, 2010 – 2018 (Usd Million)
Fig. 9 U.S. Dental Implants Market, 2010 – 2018 (Usd Million)
Fig. 10 U.S. Intraocular Lens Market, 2010 – 2018 (Usd Million)
Fig. 11 U.S. Breast Implants Market, 2010 – 2018 (Usd Million)
Fig. 12 U.S. Other Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 13 U.S. OrthopedicImplants Procedures Market, 2010 – 2018 (Million)
Fig. 14 U.S. Spinal Fusion And Fixation Procedures Market, 2010 – 2018 (Million)
Fig. 15 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018 (Million)
Fig. 16 U.S. Stenting Procedures Market, 2010 – 2018 (Million)
Fig. 17 U.S. Defibrillator Implantation Procedures Market, 2010 – 2018 (Million)
Fig. 18 U.S. Breast Augmentation Procedures Market, 2010 – 2018 (Million)
Fig. 19 Abbott Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 20 Alcon Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 21 Biomet Incorporated: Net Sales, 2009 – 2011 (Usd Million)
Fig. 22 Boston Scientific: Net Sales, 2009 – 2011 (Usd Million)
Fig. 23 Johnson & Johnson: Net Sales, 2009 – 2011 (Usd Million)
Fig. 24 Medtronic Inc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 25 St Jude Medical Inc.: Net Sales, 2009 – 2011 (Usd Million)
Fig. 26 Smith And Nephew Plc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 27 Stryker Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 28 Synthes Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 29 Zimmer Holdings Inc.: Net Sales, 2009 – 2011 (Usd Million)

Upcoming Reports:

Nanomagnetics (Materials and Devices) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The global market for nanomagnetics (materials and devices) is largely driven by the demand from the data storage sector. The data storage media is the largest end use segment, followed by diagnostics and biotechnology. Continuous new developments in the field of nanotechnology are expected to fuel the growth of the nonmagnetic market. Geographically, the U.S. is the largest market, but Japan is the fastest growing region due to its extensive work in the field, which has made it the hub for nanotechnology. Nanomagnetics is finding increased applications in medicine such as in drug...
Poland: market of unwrought technically pure zinc
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the unwrought technically pure zinc market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the unwrought technically pure zinc market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatological diagnostics market accounting for 28.7% of the total therapeutics market followed by psoriasis (26.4%), rosacea (14.9%), and atopic dermatitis (9%).  Many new players are emerging in this market as a result of a number of growth opportunities provided by this market, thus...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Early Treatment to Cure HIV virus Might not be Effective
Jul 23, 2014  
According to a research study, the virus of AIDS, HIV has the capacity of creating invulnerable strongholds in the host’s body rapidly. This has dashed hopes of early treatment for the condition, which might have been helpful to cure the virus. In one case, a baby was thought to be cured with the new treatment after its birth, however, the virus emerged couple of years later. A...
Pharmaceutical Companies in Europe to Share Deprioritized Compounds for Medical Research
Jul 23, 2014  
Seven leading drugmakers in the UK have decided to share their unused experimental medicines with British researchers involved in academic research. This move is seen as an effort to deepen relations between the pharmaceutical industry and the community of scientists in the country. The new partnership between the seven pharma companies and the Medical Research Council (MRC) was...
Typhoon Rammasun hits Yangjiang, Guangdong province
Jul 22, 2014  
The largest typhoon to hit the southern part of China in forty years has resulted in death of 17 people after wreaking havoc on Philippines. The typhoon Rammasun has resulted in deaths of eight people on the island of Hainan. Many people are recorded missing and nine of these from the Guangxi region. This typhoon caused landfall on Friday, and was reported with winds exceeding 200...
Allergan to Slash 1,500 Jobs Amid Fighting Valeant Bid
Jul 22, 2014  
Allergan, best known as the maker of Botox, has announced plans to slash 13% of its workforce, which means that 1,500 employees will be facing the axe. Allergan said that the massive layoffs are in an effort to make the company more productive and efficient. The company, based in Irvine, California, said Monday that nearly 250 vacant positions will be eliminated as part of this...
Netflix Surpasses Projected Earnings in Second Quarter of 2014 with Double the Profits
Jul 22, 2014  
Netflix, the internet video services provider, has reported that its earnings in the second quarter more than doubled. The company attributed this spike in earnings to the success of new episodes from one of its highly successful series. This has helped Netflix’s customer base to reach higher than 50 million worldwide – highest ever in the company’s history. The...